MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neurom.2024.01.005

Медицинская библиотека · Neuromodulation : journal of the International Neuromodulation Society · 2024

Effects of Transcranial Direct Current Stimulation on Clinical Outcomes, Calcitonin Gene-Related Peptide, and Pituitary Adenylate Cyclase-Activating Polypeptide-38 Levels in Menstrual Migraine.

Hasırcı Bayır Buse Rahime, Aksu Serkan, Gezegen Haşim, Karaaslan Zerrin, Yüceer Hande, Cerrahoğlu Şirin Tuba, Küçükali Cem İsmail, Kurt Adnan, Karamürsel Sacit, Yılmaz Vuslat, Baykan Betül

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

Transcranial direct current stimulation (tDCS) has been suggested as an alternative treatment option for migraine. The present study aimed to evaluate the efficacy of tDCS on clinical outcomes in addition to calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating peptide 38 (PACAP-38) levels in individuals with menstrual-related migraine (MRM) for the first time.

MATERIALS AND

METHODS

In this parallel study, 58 female patients between the ages of 18 and 45 years, including 36 with MRM and 22 with nonmenstrual migraines (nMM), were recruited. Sessions of 2-mA 20-minute anodal tDCS were administered over the left dorsolateral prefrontal cortex within three consecutive days (1:1 active and sham stimulation). Migraine attack frequency, severity, analgesic usage, CGRP, and PACAP-38 levels of the patients were evaluated before and one month after tDCS.

RESULTS

After tDCS, in the active group compared with the sham group, the frequency (p = 0.031), the severity of attacks (p = 0.003), the number of days with headache (p = 0.004), and the analgesic usage (p = 0.024) were all decreased. In both MRM and nMM groups, the frequency and severity of attacks and analgesic usage were decreased in those receiving active stimulation (p < 0.001 for each). CGRP and PACAP-38 levels were no different in the active group and the sham group after tDCS.

CONCLUSIONS

tDCS was shown to be efficacious in migraine prophylaxis and a valuable option for migraine and MRM treatment. The absence of changes in serum CGRP and PACAP-38 levels suggests that tDCS efficacy may stem from distinct cerebral electrophysiological mechanisms.

Для цитирования: Hasırcı Bayır Buse Rahime, Aksu Serkan, Gezegen Haşim, Karaaslan Zerrin, Yüceer Hande, Cerrahoğlu Şirin Tuba, Küçükali Cem İsmail, Kurt Adnan, Karamürsel Sacit, Yılmaz Vuslat, Baykan Betül. Effects of Transcranial Direct Current Stimulation on Clinical Outcomes, Calcitonin Gene-Related Peptide, and Pituitary Adenylate Cyclase-Activating Polypeptide-38 Levels in Menstrual Migraine.. Neuromodulation : journal of the International Neuromodulation Society. 2024. DOI: 10.1016/j.neurom.2024.01.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.